Trial Details
NOT_YET_RECRUITINGBasic Information
| Clinical ID | c99 |
|---|---|
| Identifier | NCT07177118 |
| Trial Title | Risankizumab for Fibrostenotic Crohn's Disease Treatment |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease|Crohn Disease and Ulcerative Colitis |
| Interventions | DRUG: Ustekinumab|DRUG: Risankizumab |
Participant Information
| Sponsor | First Affiliated Hospital of Wenzhou Medical University |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-10-20 |
|---|---|
| Primary Completion Date | 2028-06-20 |
| Completion Date | 2028-10-20 |